Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$25.13 USD
-0.21 (-0.83%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $25.12 -0.01 (-0.04%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth C Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Fresenius Medical Care AG & Co. KGaA has a market cap of $15.06B, which represents its share price of $25.66 multiplied by its outstanding shares number of 586.83M. As a large-cap company, FMS's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
FMS 25.13 -0.21(-0.83%)
Will FMS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FMS
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
Here's Why Fresenius (FMS) Looks Ripe for Bottom Fishing
FMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs
Universal Health Q2 Earnings Beat on Strong Acute Care Admissions
Here's Why Fresenius (FMS) is a Strong Value Stock
Other News for FMS
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic ...
Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)
Oakmark Global Concentrated Strategy Q2 2025 Commentary
Deutsche Bank Adjusts Price Target for Fresenius Medical (FMS) | FMS Stock News
Fresenius Medical price target raised by EUR 5 at Deutsche Bank